Yanina Balabanova

机构：Bayer (Germany) · ORCID：0000-0002-5065-4788

发表论文 83 篇 · 总被引 3417 次 · h-index 33

代表论文

Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke (2020 · Heart · 被引 45)
Renal decline in patients with non-valvular atrial fibrillation treated with rivaroxaban or warfarin: A population-based study from the United Kingdom (2022 · International Journal of Cardiology · 被引 33)
Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden (2022 · BMC Urology · 被引 27)
Incidence of hospital-acquired acute kidney injury and trajectories of glomerular filtration rate in older adults (2023 · BMC Nephrology · 被引 13)
Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden (2022 · BMJ Open · 被引 10)
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study (2024 · Journal of Thrombosis and Thrombolysis · 被引 8)